Publications by authors named "Rohan Brebion"
Article Synopsis
- Postoperative complications from paramedian forehead flap (PMFF) surgeries are uncommon, but infections are the most frequent issue, prompting a study to identify risk factors for complications and unplanned reoperations.
- Analysis of 1,592 PMFF procedures from 2007-2019 revealed that 2.7% experienced surgical site complications, with significant risk factors including recent significant weight loss, disseminated cancer, and longer operative times.
- Additionally, 2.5% of patients required unplanned reoperations, primarily linked to higher ASA class and dirty/infected wound status.
Background: Head and neck free flaps remain associated with considerable rates of take-back and prolonged hospital length of stay. However, there have been no studies on a national level benchmarking the timeline and predictors of head and neck free flap take-back.
Methods: Patients undergoing head and neck free flap reconstruction from the American College of Surgeons National Surgical Quality Improvement Program 2012-2019 database were analyzed to determine the rates of take-back.
Background: Reduction mammoplasty continues to be a commonly sought procedure with complication rates ranging from 4.3 to 8.2%.
View Article and Find Full Text PDFBackground: Abdominoplasty complication rates are among the highest for cosmetic surgery. We sought to create a validated scoring system to predict the likelihood of wound complications after abdominoplasty using a national multi-institutional database.
Methods: Patients who underwent abdominoplasty in the American College of Surgeons National Surgical Quality Improvement Program 2007-2019 database were analyzed for surgical site complications, a composite outcome of wound disruption, and surgical site infections.
Article Synopsis
- * Researchers found that when MSI2 is removed, it lowers the levels of another protein called EGFR, which is important for cancer cell growth.
- * Depleting MSI2 makes NSCLC cells, especially those with changes in EGFR, less able to grow and makes treatments that target EGFR more effective.